Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.35
01.03.23
€22.48
01.03.24
15.57%
02.03.24

HC Wainwright 
01.03.23 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€40.60
01.03.23
€54.33
01.03.24
63.79%
02.03.24

Needham & Company LLC 
01.03.23 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€40.00
01.03.23
€71.20
01.03.24
-34.50%
02.03.24

Royal Bank of Canada 
01.03.23 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
01.03.23
€14.00
-
02.03.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
01.03.23 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€6.62
01.03.23
-
01.03.24
-15.51%
17.03.23

Could be very worthwhile Investment >20% year
quelbe60 
01.03.23 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€144.58
28.02.23
-
28.02.24
14.12%
29.02.24

Guggenheim 
28.02.23 50%
buy
SCYNEXIS Inc.

Start price
Target price
Perf. (%)
€1.74
28.02.23
-
28.02.24
-11.43%
29.02.24

Guggenheim 
28.02.23 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€40.40
28.02.23
€56.63
28.02.24
-32.18%
29.02.24

Needham & Company LLC 
28.02.23 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€94.17
28.02.23
€111.20
28.02.24
-13.41%
29.02.24

Stifel Nicolaus 
28.02.23 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€94.17
28.02.23
€117.80
28.02.24
-13.41%
29.02.24

Guggenheim 
28.02.23 50%
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€214.00
28.02.23
€329.84
28.02.24
-26.17%
29.02.24

Guggenheim 
28.02.23 50%
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€167.56
28.02.23
€159.97
28.02.24
25.57%
29.02.24

Guggenheim 
28.02.23 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€77.50
28.02.23
€95.04
28.02.24
93.55%
29.02.24

Guggenheim 
28.02.23 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€19.63
28.02.23
€23.50
28.02.24
12.07%
29.02.24

HC Wainwright 
28.02.23 50%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€53.02
28.02.23
€67.71
28.02.24
-49.45%
29.02.24

Citigroup Inc. 
28.02.23 50%
sell
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.32
28.02.23
€1.88
28.02.24
-50.72%
29.02.24

The Goldman Sachs Group, Inc. 
28.02.23 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€133.16
28.02.23
-
28.02.24
-12.89%
29.02.24

StockNews.com 
28.02.23 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€1.95
28.02.23
-
28.02.24
41.64%
29.02.24

StockNews.com 
28.02.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
28.02.23
-
28.02.24
-
29.02.24

StockNews.com 
28.02.23 50%
buy
Roche Holding AG ADR

Start price
Target price
Perf. (%)
€34.65
27.02.23
-
27.02.24
-13.48%
28.02.24

Societe Generale 
27.02.23 50%
buy
iBio Inc.

Start price
Target price
Perf. (%)
€1.18
27.02.23
€1.10
27.02.24
-16.47%
26.04.23

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
geldnutzer 
27.02.23 60%
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.33
27.02.23
€0.50
27.02.24
-10.72%
02.03.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
27.02.23 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.97
27.02.23
€15.12
27.02.24
-63.50%
28.02.24

Wedbush 
27.02.23 50%
buy
GSK plc ADR

Start price
Target price
Perf. (%)
€33.00
27.02.23
-
27.02.24
18.79%
28.02.24

The Goldman Sachs Group, Inc. 
27.02.23 50%
sell
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
27.02.23
-
27.02.24
-
28.02.24

StockNews.com 
27.02.23 50%